The association of p21, inhibin, and Tob-1 expression with the clinicopathological characteristics of benign and malignant colorectal lesions

Bibliographic Information
Authors: Moussa M.; Abdullah A.M.; Youssef M.M.; Elwi D.; Helal N.S.
Journal: Beni-Suef University Journal of Basic and Applied Sciences
Publisher: Springer Science and Business Media Deutschland GmbH
Publication Date: 11 February 2024
Volume / Issue: Volume 13 / Issue 1
Article No.: 14
ISSN: 23148535
DOI: 10.1186/s43088-024-00471-3
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Moussa M., Department of Pathology, Theodor Bilharz Research Institute, El-Nile Street, Warrak El-Hadar, Giza, Imbaba, 12411, Egypt; Abdullah A.M., Department of Pathology, Theodor Bilharz Research Institute, El-Nile Street, Warrak El-Hadar, Giza, Imbaba, 12411, Egypt; Youssef M.M., Faculty of Pharmacy, Egyptian-Russian University, Cairo, Egypt; Elwi D., Department of Pathology, Faculty of Medicine, Cairo University, Giza, Egypt; Helal N.S., Department of Pathology, Theodor Bilharz Research Institute, El-Nile Street, Warrak El-Hadar, Giza, Imbaba, 12411, Egypt
Abstract
Background: Worldwide, colorectal cancer (CRC) is the third most common cancer and the second most common cause of cancer-related deaths. p21, inhibin, and Tob-1 are tumor suppressors that play a role in the development and progression of several cancers, however, their role in CRC is not well-established. This study aims to evaluate the expression of these proteins by immunohistochemistry and correlate their expression with the clinicopathological characteristics of CRCs and preneoplastic lesions [adenomas and ulcerative colitis] to study the potential for their use as targeted therapies. The study was performed on sections of 30 CRCs, 30 adenomas, 30 UC, 30 chronic colitis, and 20 controls. Results: p21 expression was lower in CRCs and adenomas compared to inflammatory lesions (chronic colitis and UC). High-grade CRCs, adenomas with high-grade dysplasia, and UC with dysplasia showed insignificantly lower expression compared to their counterparts. Inhibin expression was absent in CRCs; however, its expression was higher in chronic colitis than in UC and adenomas. Adenomas with high-grade dysplasia and UC with dysplasia showed insignificantly higher expression than their counterparts. Tob-1 expression increased significantly from chronic colitis to UC to adenomas to CRCs. High-grade CRCs, adenomas with high-grade dysplasia, and UC with dysplasia showed higher expression compared to their counterparts. Conclusions: Decreased p21 and increased inhibin and Tob-1 expressions are associated with the progression of adenomas and UC to more dysplastic lesions, then possibly to CRC. Despite being tumor suppressors, the studied proteins may potentially have tumor-promoting properties. They can be useful targets for therapeutic intervention. © The Author(s) 2024.
Keywords
Chronic colitis; Colon adenoma; Colon cancer; Inhibin; p21; Risk assessment; Tob-1; Ulcerative colitis
Citation Information
Scopus Citations: 0
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
